According to the Washington Post, “Democrats are trying to breathe new life into their drug pricing efforts ….
“The influential Senate Finance Committee is eyeing holding a hearing on the cost of medicines as Democrats hope to craft a scaled-back version of President Biden’s economic package, according to four people with knowledge of the matter.
“Though not yet official, the hearing could occur as soon as this month, per three of the people, who spoke on the condition of anonymity to describe the private discussions. It would likely center around the urgency of addressing high pharmaceutical prices. The idea, in part, is to highlight the need to pass drug pricing legislation soon, according to a Senate Democratic aide.
“Democrats’ plan to lower the cost of prescription drugs has broad support within the party after lawmakers clinched a deal following a frenzy of negotiations last fall. And doing so is important to Democrats, who are seeking legislative victories ahead of the midterms.”
As we have pointed out before, no Republican Senator has indicated a willingness to vote for the prescription drug price legislation being worked on by the Democrats so the Democrats must be able to produce a bill that all of them will support if they are to pass it in the Senate.
